Yahoo Web Search

Search results

1. • 

     Cara Therapeutics (NASDAQ:CARA shareholders incur further losses as stock declines 8.8% this week,...

     Simply Wall St. via Yahoo Finance· 1 year ago

     For many investors, the main point of stock picking is to generate higher returns than the overall...

2. • 

     Cara Therapeutics, Inc. (NASDAQ:CARA) is a favorite amongst institutional investors who own 65%

     Simply Wall St. via Yahoo Finance· 1 year ago

     Key Insights Institutions' substantial holdings in Cara Therapeutics implies that they have...

3. • 

     Wall Street Analysts See a 133% Upside in Cara (CARA): Can the Stock Really Move This High?

     Zacks via Yahoo Finance· 2 years ago

     The mean of analysts' price targets for Cara (CARA) points to a 132.9% upside in the stock. While...

4. • 

     Cara Therapeutics, Inc.'s (NASDAQ:CARA) P/S Is On The Mark

     Simply Wall St. via Yahoo Finance· 1 year ago

     You may think that with a price-to-sales (or "P/S") ratio of 4.4x Cara Therapeutics, Inc....

5. • 

     Cara Therapeutics, Inc. (NASDAQ:CARA) Analysts Just Cut Their EPS Forecasts Substantially

     Simply Wall St. via Yahoo Finance· 1 year ago

     Market forces rained on the parade of Cara Therapeutics, Inc. (NASDAQ:CARA) shareholders today, when...

6. • 

     Cara Therapeutics (CARA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

     Zacks via Yahoo Finance· 2 years ago

     Cara (CARA) possesses the right combination of the two key ingredients for a likely earnings beat in...

7. • 

     News Flash: Analysts Just Made A Substantial Upgrade To Their Cara Therapeutics, Inc. (NASDAQ:CARA)...

     Simply Wall St. via Yahoo Finance· 7 months ago

     Cara Therapeutics, Inc. (NASDAQ:CARA) shareholders will have a reason to smile today, with the...

8. • 

     Cara Therapeutics (CARA) Reports Q3 Loss, Tops Revenue Estimates

     Zacks via Yahoo Finance· 2 years ago

     Cara (CARA) delivered earnings and revenue surprises of -2.38% and 28.91%, respectively, for the...

9. • 

     Companies Like Cara Therapeutics (NASDAQ:CARA) Could Be Quite Risky

     Simply Wall St. via Yahoo Finance· 9 months ago

     Even when a business is losing money, it's possible for shareholders to make money if they buy a...

10. • 

      CARA's Late-Stage Skin Disease Study Fails, Stock Plummets 49%

      Zacks via Yahoo Finance· 6 months ago

      CARA discontinues the clinical program of oral difelikefalin for pruritus associated with atopic...